SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from UMeWorld Inc. (UMEW) (CIK 0001114936) (UMEW) — Oct 1, 2004

UMeWorld Inc. (UMEW) (CIK 0001114936)
Date: Oct. 1, 2004 · CIK: 0001114936 · Accession: 0001144204-04-015578

AI Filing Summary & Sentiment

Date
October 1, 2004
Author
/s/ David M. Pedley
Form
CORRESP
Company
UMeWorld Inc. (UMEW) (CIK 0001114936)

Letter

[LETTERHEAD OF PEDLEY ZIELKE GORDINIER & PENCE, PLLC] ATTORNEYS AT LAW 2000 MEIDINGER TOWER 462 SOUTH FOURTH AVENUE LOUISVILLE, KENTUCKY 40202-2555 (502) 589-4600 FAX (502) 584-0422 WWW.PZGP.COM October 1, 2004 VIA EDGAR FILING United States Securities and Exchange Commission Division of Corporate Finance 450 Fifth Street, N.W. Washington, D.C. 20549

Re: Response to Comments on the Registration Statement on Form SB-2 of AlphaRx, Inc.

Dear Mr. Belliston:

The undersigned has acted as counsel to AlphaRx, Inc., during AlphaRx's registration of securities on Form SB-2. We are in receipt of the Securities and Exchange Commission's comment letter, dated September 17, 2004. In response to your letter, please note that AlphaRx has made the following changes in its first amendment to the registration statement:

1. In response to Comment #1, of your letter, AlphaRx has adjusted the number of shares being registered in the selling security holders table to reflect the correct number of 93,905,994 shares.

2. In response to Comment #2 of your letter, AlphaRx has identified all broker-dealers as underwriters except for those broker-dealers whose shares were issued as compensation for underwriting activities.

3. In response to Comment #3 of your letter, AlphaRx has noted that all affiliates of all broker-dealers identified in the prospectus obtained their shares in the ordinary course of business and that there is no agreement or understanding with any person to distribute any shares.

4. In response to Comment #4 of your letter, AlphaRx has obtained consent letters for both its present and past accountants and has submitted those as exhibits to its amended registration statement.

Furthermore, AlphaRx acknowledges and understands that if the Commission or its staff declare its filing effective that it does not foreclose the Commission from taking

<PAGE>

PEDLEY ZIELKE GORDINIER & PENCE, PLLC

any action with respect to the filing, or relieve AlphaRx from its full responsibility for the adequacy and accuracy of the disclosures contained in its prospectus. Additionally, AlphaRx's understands and acknowledges that declaring the prospectus effective does not allow AlphaRx to raise this fact as a defense to any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If you have any further questions or comments, please do not hesitate to contact me.

Sincerely,
/s/ David M. Pedley
-------------------
David M. Pedley

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
              [LETTERHEAD OF PEDLEY ZIELKE GORDINIER & PENCE, PLLC]
                                ATTORNEYS AT LAW
                              2000 MEIDINGER TOWER
                             462 SOUTH FOURTH AVENUE
                         LOUISVILLE, KENTUCKY 40202-2555
                                 (502) 589-4600
                               FAX (502) 584-0422
                                  WWW.PZGP.COM

                                 October 1, 2004

VIA EDGAR FILING
United States Securities and Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, D.C. 20549

Re:     Response to Comments on the Registration Statement on Form SB-2 of
        AlphaRx, Inc.

Dear Mr. Belliston:

The undersigned has acted as counsel to AlphaRx, Inc., during AlphaRx's
registration of securities on Form SB-2. We are in receipt of the Securities and
Exchange Commission's comment letter, dated September 17, 2004. In response to
your letter, please note that AlphaRx has made the following changes in its
first amendment to the registration statement:

1.       In response to Comment #1, of your letter, AlphaRx has adjusted the
         number of shares being registered in the selling security holders table
         to reflect the correct number of 93,905,994 shares.

2.       In response to Comment #2 of your letter, AlphaRx has identified all
         broker-dealers as underwriters except for those broker-dealers whose
         shares were issued as compensation for underwriting activities.

3.       In response to Comment #3 of your letter, AlphaRx has noted that all
         affiliates of all broker-dealers identified in the prospectus obtained
         their shares in the ordinary course of business and that there is no
         agreement or understanding with any person to distribute any shares.

4.       In response to Comment #4 of your letter, AlphaRx has obtained consent
         letters for both its present and past accountants and has submitted
         those as exhibits to its amended registration statement.

      Furthermore, AlphaRx acknowledges and understands that if the Commission
or its staff declare its filing effective that it does not foreclose the
Commission from taking

<PAGE>

PEDLEY ZIELKE GORDINIER & PENCE, PLLC

any action with respect to the filing, or relieve AlphaRx from its full
responsibility for the adequacy and accuracy of the disclosures contained in its
prospectus. Additionally, AlphaRx's understands and acknowledges that declaring
the prospectus effective does not allow AlphaRx to raise this fact as a defense
to any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.

      If you have any further questions or comments, please do not hesitate to
contact me.

                                                Sincerely,

                                                /s/ David M. Pedley
                                                -------------------
                                                David M. Pedley

</TEXT>
</DOCUMENT>